Download presentation
Presentation is loading. Please wait.
1
Organophosphate Pesticide Poisoning
Bishan Rajapakse MBChB Otago Emergency Medicine Advanced Trainee, MPhil Student (ANU), South Asian Clinical Toxicology Research Collaboration Sri Lanka
2
The Case…. Picture yourself in Anuradhapura hospital Sri Lanka – ED/ Medical SHO Ward 6 , teaming with patients…. Charge Sister tells you there is a sick patient 36yo F Taken 100mls of Dimethoate after a domestic argument There’s nowhere to run, or hide…. So you see the patient – what do you do?
3
Organophosphate Pesticide Poisoning
4
Organophosphate Poisoning in Sri Lanka
Organophosphate pesticide (OP) poisoning kills 300,000 worldwide In Sri Lanka these are mostly impulsive deliberate self-poisoning in young people
5
Organophosphate Poisoning in Sri Lanka
Case Fatality rates (CFR) 10-20% for most 50-70% for some OP’s In west CFR 0.3% from all poisons Multifactorial Toxicity of OP’s Patient transport Lack of resources Training Although less common OP Poisoning is still a problem in West Occupational exposure Threat of Chemical warfare
6
Poisoning at Anuradhapura Hospital in 2005
Admissions Death Case Fatality Acid 2 0% Carbamate 105 3 3% Hydrocarbon 62 Medicine 254 1% Oleander 380 8 2% OP 408 44 11% Other Pest. 311 12 4% Paraquat 59 21 35.50% Unknown 128 7 5.50% Un.pesticide 127 13 10% TOTAL 1836 111 6%
7
Mechanism of OP’s
8
Simplified Acute OP Toxicity
Inactivation of acetylcholinesterase enzyme Organophosphate
9
Pharmacology of Cholinomimetics according to Katzung
Structure Simple Alcohols eg edrophonium Carbamates Eg Neostigmine and Physostigmine (tertiary) Organophosphates eg Parathion
10
Pharmacokinetics Pharmacodynamics Cholinomimetic Simple Alcohols
Eg edrophonium Polar, not fat soluble Electrostatically bind to active site of AChE (short lived 2-10mins) Carbamates Tertiary – well absorbed, fat soluble Eg physostigmine Quaternary- polar, negligible CNS distribution 2 step hydrolysis of to form Carbamoylated enzyme-inhibitor complex (30mins to 6 hours) - Reversible inhibitors Organophosphates Variable over 50,000 varieties Most fat soluble- thus well absorbed and dangerous to humans (Echothiopate is one of the water soluble varieties) Thiophosphates - need conversion to Oxon form to work Malathion are metabolised to inactive forms in birds and mammals but not fish Binding and hydrolysis to form Phosphorylated enzyme-inhibitor complex Covalent phosphorus-enzyme hydrolyses slowly (hundreds of hours sometimes) Irreversible inhibitors -May undergo Aging (different rates for different OPs) with no oxime regeneration thereafter
11
} Clinical Syndrome Respiratory failure + Death Clinical Syndrome
Acute Cholinergic: Central Peripheral Muscarinic Peripheral Nicotinic Intermediate Syndrome OPIDN: Delayed peripheral neuropathy Neurocognitive dysfunction + Death
12
Cholinergic Effects D iarrhoea U rination M iosis
B radycardia, Bronchorrhoea, Bronchospasm E mesis L acrimation S alivation
13
Nicotinic Effects respiratory arrest cardiorespiratory arrest
Respiratory difficulty respiratory arrest diaphragmatic weakness Muscle Weakness fasiculations clonus tremor Stimulation of sympathetic nervous system Mydriasis, hypertension, tachycardia re-entrant dysrhythmias cardiorespiratory arrest
14
CNS effects Malaise Memory loss Confusion Disorientation Delirium
Seizures Respiratory centre depression or dysfunction Coma
15
Intermediate Syndrome
Delayed Respiratory Failure Proximal muscle weakness and cranial nerve lesions Typically 1-4 days after cholinergic crisis has resolved Prolonged Effects on Nicotinic receptors Primary motor end plate degeneration Clinical importance Delayed respiratory failure leads to death if not aware of it or prepared for it Wadia et. al 1974 :Type II Paralysis, Senanayake and Karalliedde 1987
16
Chronic Effects Organophosphate induced delayed neuropathy (OPIDN)
1-3weeks Peripheral neuropathy Axonopathy due to Neuropathy Target Esterases (NTE) Chronic organophosphate induced neuropsychiatric disorder (COPIND)
17
Management Resuscitation Atropinisation of symptomatic patients
The priorities in management are to: Resuscitation Atropinisation of symptomatic patients Decontamination Other Treatments - Oximes
18
Antidotes Does treatment affect outcome Atropine Oximes Expensive
Intermediate Syndrome? OPIDN? ? Dose ? Duration ? Effectiveness
19
Does the patient need atropine?
How much and for how long
20
Scheme of atropinization (endpoints to be reached)
5 1 2 3 4 m i n a f t e r s o p d 8 6 A q u P y l g c b h E x v w ( H ) B M z C D S . > / N Eddleston M, Buckley NA, Mohamed F, Senarathna L, Hittarage A, Dissanayake W, Azhar S, Sheriff MHR, Dawson AH. Speed of initial atropinisation in significant organophosphorus pesticide poisoning - a comparison of recommended regimens. Journal of Toxicology – Clinical Toxicology 2004;6:
21
Atropine Loading Maintenance Endpoints Withdrawal
Doubling dose regime e.g mgs every 5 minutes Maintenance Continuous infusion < 3mg/hr 10-20% of loading dose/hour Endpoints Clear chest on auscultation with no wheeze Heart rate >80 beats/min Withdrawal Atropine toxicity Clinical Improvement
22
What if you give too much Atropine ?
Anticholinergic Syndrome: Hot as hell Blind as a bat Red as a beet Dry as a bone Mad as a hatter A sensitive indicator for ingestion, but poor predictor for toxicity. Full syndrome is rare The classic anticholinergic syndrome is described as below:- Hot as hell Blind as a bat Red as a beet Dry as a bone Mad as a hatter Patients may have:- Elevated BP, red dry skin, dilated pupils, bowel sounds, urinary retention, delirium and convulsion It can occur with any anticholinergic drugs e.g. cogentin, anticholinergic plants e.g. datura, as well as antihistamines, antidepressant drugs and antipsychotic drugs.
23
Gastrointestinal Decontamination
? Gastrointestinal Decontamination 3
24
Our Decision should depend on a risk/benefit analysis
Nothing Emesis Gastric Lavage Activated Charcoal Whole bowel irrigation 3
25
Risk of Intervention Aspiration Trauma Electrolyte Abnormalities
Impaired GCS + Unprotected Airway Emesis, Lavage, Charcoal (worse with cathartics) Trauma Oesphageal Injury Emesis, Lavage, Charcoal Electrolyte Abnormalities Forced Emesis, Cathartics Cardiac Arrest Toxin induced bradycardia + Vagal Tone Induced emesis, Lavage Cost
26
Summary of Experimental Evidence
Ideal settings Little benefit in outcomes after 1 hour Activated Charcoal is equivalent or better than emesis or lavage Position statement: single-dose activated charcoal. J Toxicol Clin Toxicol 1997;35: Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. J Toxicol Clin Toxicol 1999;37:
27
Oximes Ineffective in some situations
Ageing Variation between organophosphates Effective protocols not established Variation in use Zero – 24 grams a day Expensive USA $ / gram India $6- 9 / gram Sri Lanka 55 cents / gram Unlikely to address Non-ACh effects
28
Alternate sites for antidotes
Protect AChE Supply AChE Reduce ACh Protect ACh Receptor Reduce OP Load Multiple Mechanisms
29
Other Treatments under investigation
Magnesium Reduces acetylcholine release Blockage pre-synaptic calcium channels Limited human studies Clonidine Decrease the presynaptic synthesis and release of acetylcholine. Central nervous system > peripheral cholinergic synapses Diazepam Diazepam reduces respiratory failure (rats) and cognitive deficit (primates) Postulate “uncoordinated stimulation of the respiratory centres decreases phrenic nerve output”.
30
The Case…. Picture yourself in Anuradhapura hospital Sri Lanka – ED/ Medical SHO Ward 6 , teaming with patients…. Charge Sister tells you there is a sick patient 36yo F Taken 100mls of Dimethoate after a domestic argument There’s nowhere to run, or hide…. So you see the patient – what do you do?
31
Summary OP’s are Indirect Cholinomimetic Effects Treatment
Block AChE, prolonged duration of ACh in synapse Effects Muscarinic, Nicotinic, CNS Respiratory failure and Death result from this Treatment ABC’s, Atropine, Decontaminate, Oximes Important also in West
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.